In welke vorm is Yorvipath beschikbaar?

Yorvipath: INJECTION, SOLUTION 420 ug/1.4mL (SUBCUTANEOUS)

Wie produceert Yorvipath?

Ascendis Pharma, Endocrinology, Inc.

Yorvipath: ATC H05AA02. ATC is de WHO-classificatie van geneesmiddelen.

OTC

420 ug/1.4mL, Injection, solution

INN: PALOPEGTERIPARATIDE

Bijgewerkt: 2026-04-25

Verkrijgbaar in:

🇨🇿🇬🇧🇯🇵🇸🇰

Vorm

INJECTION, SOLUTION

Dosering

420 ug/1.4mL

Toedieningsweg

SUBCUTANEOUS

Bewaring

—

Over dit product

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.